Literature DB >> 32071440

Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Roger D Klein1,2, Scott J Hultgren3,4.   

Abstract

Urinary tract infections (UTIs) are common, recurrent infections that can be mild to life-threatening. The continued emergence of antibiotic resistance, together with our increasing understanding of the detrimental effects conferred by broad-spectrum antibiotic use on the health of the beneficial microbiota of the host, has underscored the weaknesses in our current treatment paradigm for UTIs. In this Review, we discuss how recent microbiological, structural, genetic and immunological studies have expanded our understanding of host-pathogen interactions during UTI pathogenesis. These basic scientific findings have the potential to shift the strategy for UTI treatment away from broad-spectrum antibiotics targeting conserved aspects of bacterial replication towards pathogen-specific antibiotic-sparing therapeutics that target core determinants of bacterial virulence at the host-pathogen interface.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32071440      PMCID: PMC7942789          DOI: 10.1038/s41579-020-0324-0

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  184 in total

1.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying.

Authors:  Fredrik Sundén; Lars Håkansson; Eva Ljunggren; Björn Wullt
Journal:  J Urol       Date:  2010-05-16       Impact factor: 7.450

3.  In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.

Authors:  Nastaran Sadat Savar; Ali Jahanian-Najafabadi; Mehdi Mahdavi; Mohammad Ali Shokrgozar; Anis Jafari; Saeid Bouzari
Journal:  J Biotechnol       Date:  2014-02-12       Impact factor: 3.307

4.  Strategy to reduce E. coli bacteraemia based on cohort data from a London teaching hospital.

Authors:  Desmond Hsu; Mark Melzer
Journal:  Postgrad Med J       Date:  2018-02-20       Impact factor: 2.401

5.  Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Authors:  George G Zhanel; Tamiko L Hisanaga; Nancy M Laing; Melanie R DeCorby; Kim A Nichol; Lorraine P Palatnik; Jack Johnson; Ayman Noreddin; Godfrey K M Harding; Lindsay E Nicolle; Daryl J Hoban
Journal:  Int J Antimicrob Agents       Date:  2005-11       Impact factor: 5.283

Review 6.  COX-1 and COX-2 inhibitors.

Authors:  C J Hawkey
Journal:  Best Pract Res Clin Gastroenterol       Date:  2001-10       Impact factor: 3.043

7.  Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Authors:  Kanna Nagamatsu; Thomas J Hannan; Randi L Guest; Maria Kostakioti; Maria Hadjifrangiskou; Jana Binkley; Karen Dodson; Tracy L Raivio; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

8.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

9.  Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract.

Authors:  Jennifer N Walker; Ana L Flores-Mireles; Chloe L Pinkner; Henry L Schreiber; Matthew S Joens; Alyssa M Park; Aaron M Potretzke; Tyler M Bauman; Jerome S Pinkner; James A J Fitzpatrick; Alana Desai; Michael G Caparon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 10.  Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  Sirijan Santajit; Nitaya Indrawattana
Journal:  Biomed Res Int       Date:  2016-05-05       Impact factor: 3.411

View more
  61 in total

Review 1.  Tissue-resident memory T cells in the urogenital tract.

Authors:  Loreto Parga-Vidal; Michiel C van Aalderen; Regina Stark; Klaas P J M van Gisbergen
Journal:  Nat Rev Nephrol       Date:  2022-01-25       Impact factor: 28.314

2.  Bladder infection with uropathogenic Escherichia coli increases the excitability of afferent neurons.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Sheldon I Bastacky; Dennis R Clayton; Wily G Ruiz; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-15

3.  Uropathogenic Escherichia coli subverts mitochondrial metabolism to enable intracellular bacterial pathogenesis in urinary tract infection.

Authors:  Connor J Beebout; Gabriella L Robertson; Bradley I Reinfeld; Alexandra M Blee; Grace H Morales; John R Brannon; Walter J Chazin; W Kimryn Rathmell; Jeffrey C Rathmell; Vivian Gama; Maria Hadjifrangiskou
Journal:  Nat Microbiol       Date:  2022-08-22       Impact factor: 30.964

4.  Rapid Fluorescence Sensor Guided Detection of Urinary Tract Bacterial Infections.

Authors:  Lei Zhang; Bing Wang; Guo Yin; Jue Wang; Ming He; Yuqi Yang; Tiejie Wang; Ting Tang; Xie-An Yu; Jiangwei Tian
Journal:  Int J Nanomedicine       Date:  2022-08-26

5.  Gardnerella Exposures Alter Bladder Gene Expression and Augment Uropathogenic Escherichia coli Urinary Tract Infection in Mice.

Authors:  Nicole M Gilbert; Valerie P O'Brien; Chevaughn Waller; Ekatherina Batourina; Cathy Lee Mendelsohn; Amanda L Lewis
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

6.  Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.

Authors:  Lotte Jakobsen; Carina Vingsbro Lundberg; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

7.  Local induction of bladder Th1 responses to combat urinary tract infections.

Authors:  Jianxuan Wu; Chunjing Bao; R Lee Reinhardt; Soman N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

Review 8.  The microbiome and host mucosal interactions in urinary tract diseases.

Authors:  Bernadette Jones-Freeman; Michelle Chonwerawong; Vanessa R Marcelino; Aniruddh V Deshpande; Samuel C Forster; Malcolm R Starkey
Journal:  Mucosal Immunol       Date:  2021-02-04       Impact factor: 7.313

9.  Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection.

Authors:  Anne M Butler; Michael J Durkin; Matthew R Keller; Yinjiao Ma; Vikas R Dharnidharka; William G Powderly; Margaret A Olsen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-04-13       Impact factor: 2.732

10.  Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry for Identification of Microorganisms in Clinical Urine Specimens after Two Pretreatments.

Authors:  Deru Lei; Peiying Chen; Xueting Chen; Yujie Zong; Xiangyang Li
Journal:  Pol J Microbiol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.